Rockwell Medical (RMTI) Income from Continuing Operations (2010 - 2026)
Rockwell Medical (RMTI) reported Income from Continuing Operations of 1725000.0 for Q1 2026, down 9.8% on a YoY basis from 1912473.54 in Q1 2025, and down 169.53% quarter-over-quarter from 640000.0 in Q4 2025.
Rockwell Medical (RMTI) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Rockwell Medical has reported Income from Continuing Operations for 17 years, with the latest figure at 1725000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 9.8% year-over-year to 1725000.0; the trailing twelve-month figure through Mar 2026 stood at 5735000.0 (down 1355.58% YoY), and the FY2025 full-year result was 5581000.0, down 907.4% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1725000.0, down from 640000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 1664000.0 in Q3 2024, with the low at 7166000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 2076764.71 across 5 years, with a median of 1731000.0 in 2024.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations soared 179.54% — and 2025, when it sank 632.88%.
- Rockwell Medical's Income from Continuing Operations stood at 2362000.0 in 2022, then surged by 31.71% to 1613000.0 in 2023, then soared by 51.7% to 779000.0 in 2024, then grew by 17.84% to 640000.0 in 2025, then slumped by 169.53% to 1725000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 1725000.0 (Q1 2026), 640000.0 (Q4 2025), and 1814000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Rockwell Medical | 26.01 Mn | 2.12 Mn | 2.90 Mn | -1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.73 Mn |
| Dec 31, 2025 | -640,000.00 |
| Sep 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | -1.56 Mn |
| Mar 31, 2025 | -1.57 Mn |
| Dec 31, 2024 | -779,000.00 |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 292,000.00 |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2023 | -2.09 Mn |
| Jun 30, 2023 | -3.31 Mn |
| Mar 31, 2023 | -1.75 Mn |
| Dec 31, 2022 | -2.36 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -4.97 Mn |
| Mar 31, 2022 | -7.17 Mn |
| Dec 31, 2021 | -8.94 Mn |
| Sep 30, 2021 | -7.58 Mn |
| Jun 30, 2021 | -8.40 Mn |